Toshimi Kimura
Impact in
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 22
- Antibiotics Pharmacokinetics and Efficacy 22
-
- Antimicrobial Resistance in Staphylococcus 11
- Antifungal resistance and susceptibility 8
- Co-authors
- Yoshio Takesue (18 shared papers)Yukihiro Hamada (22 shared papers)Kazuaki Matsumoto (18 shared papers)Yoshiko Takahashi (14 shared papers)Satoshi Fujii (8 shared papers)Kazutaka Oda (11 shared papers)Yuki Hanai (9 shared papers)Hiroshige Mikamo (4 shared papers)
- Journals
- British Journal of Clinical Pharmacology (3 papers)Biological and Pharmaceutical Bulletin (3 papers)Clinical Therapeutics (2 papers)Clinical and Translational Science (2 papers)EXPERIMENTAL ANIMALS (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Toshimi Kimura
58 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 84
- Infectious Diseases 576
- Pharmacology 419
- Clinical Biochemistry 140
- Applied Microbiology and Biotechnology 29
- Molecular Medicine 36
Countries citing papers authored by Toshimi Kimura
This map shows the geographic impact of Toshimi Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshimi Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshimi Kimura more than expected).
Fields of papers citing papers by Toshimi Kimura
This network shows the impact of papers produced by Toshimi Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshimi Kimura. The network helps show where Toshimi Kimura may publish in the future.
Co-authors
The 25 scholars most cited alongside Toshimi Kimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 207 | |
| 2 | 2013 | 141 | |
| 3 | 2021 | 108 | |
| 4 | 2012 | 90 | |
| 5 | 2022 | 85 | |
| 6 | 2004 | 69 | |
| 7 | 2021 | 49 | |
| 8 | 2022 | 44 | |
| 9 | 2020 | 42 | |
| 10 | 2005 | 26 | |
| 11 | 2021 | 25 | |
| 12 | 2020 | 23 | |
| 13 | 2022 | 21 | |
| 14 | 2021 | 19 | |
| 15 | 2021 | 18 | |
| 16 | 2013 | 18 | |
| 17 | 1996 | 16 | |
| 18 | 2023 | 12 | |
| 19 | 2021 | 11 | |
| 20 | 2019 | 9 |
About Toshimi Kimura
Toshimi Kimura is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 64 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Antimicrobial Resistance in Staphylococcus (11 papers), Antifungal resistance and susceptibility (8 papers), Acute Lymphoblastic Leukemia research (5 papers), Renal Transplantation Outcomes and Treatments (4 papers), Pneumonia and Respiratory Infections (4 papers), Neonatal Health and Biochemistry (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Infectious Diseases (576 citations), Pharmacology (419 citations), Clinical Biochemistry (140 citations), Applied Microbiology and Biotechnology (29 citations) and Molecular Medicine (36 citations). Toshimi Kimura has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yoshio Takesue, Yukihiro Hamada, Kazuaki Matsumoto, Yoshiko Takahashi, Satoshi Fujii, Kazutaka Oda, Yuki Hanai, Hiroshige Mikamo, Yusuke Tanigawara and Shunji Takakura. Their work appears in journals such as British Journal of Clinical Pharmacology, Biological and Pharmaceutical Bulletin, Clinical Therapeutics, Clinical and Translational Science and EXPERIMENTAL ANIMALS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.